Key players in Antibody-Drug Conjugates
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  AstraZeneca |
astrazeneca.com (opens in a new tab) | 957 reports |
| 2 |  Daiichi Sankyo Company |
daiichisankyo.com (opens in a new tab) | 165 reports |
| 3 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 4 |  Gilead Sciences, Inc. |
gilead.com (opens in a new tab) | 297 reports |
| 5 |  Roche |
roche.com (opens in a new tab) | 1,485 reports |
| 6 |  AbbVie Inc. |
abbvie.com (opens in a new tab) | 1,254 reports |
Also active in Antibody-Drug Conjugates
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
GSK PLC
Eli Lilly and Company
Merck & Co., Inc.
Johnson & JohnsonSource: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Top trial sponsors in Antibody-Drug Conjugates
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- AstraZeneca 21 active trials on ClinicalTrials.gov (opens in a new tab)
- Daiichi Sankyo Company 8 active trials on ClinicalTrials.gov (opens in a new tab)
- BioNTech 7 active trials on ClinicalTrials.gov (opens in a new tab)
- Hansoh BioMedical R&D Company 7 active trials on ClinicalTrials.gov (opens in a new tab)
- MediLink Therapeutics (Suzhou) Co., Ltd. 6 active trials on ClinicalTrials.gov (opens in a new tab)
- EMD Serono Research & Development Institute, Inc. 6 active trials on ClinicalTrials.gov (opens in a new tab)
- GSK PLC 6 active trials on ClinicalTrials.gov (opens in a new tab)
- Eli Lilly and Company 5 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Antibody-Drug Conjugates reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Antibody-Drug Conjugates report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.